MedPath

Sterling-Knight Pharmaceuticals, LLC

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

22

FDA:22

Drug Approvals

Zyvana

Approval Date
Feb 22, 2021
FDA

Metaxalone

Approval Date
Jun 3, 2020
FDA

Esomeprazole strontium

Approval Date
Apr 20, 2020
FDA

Prenara

Approval Date
Mar 3, 2020
FDA

Not Applicable

Approval Date
Feb 18, 2020
FDA

Luvira

Approval Date
Jan 28, 2020
FDA

FENOPROFEN CALCIUM

Approval Date
Jan 24, 2020
FDA

Revesta

Approval Date
Dec 16, 2019
FDA

Vexasyn

Approval Date
Jul 31, 2018
FDA

Not Applicable

Approval Date
Jul 13, 2017
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.